"Ransomware Strikes Biotech Firm Researching Possible COVID-19 Treatments"

10x Genomics Inc., a California-based biotechnology company, recently revealed in a financial disclosure form filed to the U.S. Securities and Exchange Commission that it was targeted by an attempted ransomware attack that also resulted in the theft of data. The company is a part of the global effort to learn more about the coronavirus to develop possible treatments for the disease. According to the security firm, Under the Breach, attackers had used ransomware known as REvil/Sodinokibi to steal one terabyte from 10x Genomics, consisting of company usernames, internal password policies, domain information, and an employee database. The hackers posted a sample file containing this information to prove their legitimacy. This article continues to discuss the attempted ransomware attack on 10x Genomics, the type of data compromised in the attack, past ransomware attacks on healthcare organizations, and how cybersecurity practitioners are helping the healthcare sector during the COVID-19 crisis. 

Cyber Scoop reports "Ransomware Strikes Biotech Firm Researching Possible COVID-19 Treatments"